Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells - PubMed (original) (raw)
. 2002 Jun 21;277(25):22573-80.
doi: 10.1074/jbc.M203009200. Epub 2002 Apr 17.
Affiliations
- PMID: 11960994
- DOI: 10.1074/jbc.M203009200
Free article
Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells
Jila Bakker et al. J Biol Chem. 2002.
Free article
Abstract
During the pathogenesis of human hepatocellular carcinoma (HCC), the CpG island encompassing the pi-class glutathione S-transferase gene (GSTP1) becomes hypermethylated. Repression of transcription accompanying CpG island hypermethylation has been proposed to be mediated by methyl-CpG binding domain (MBD) proteins. We report here that inhibition of transcription from hypermethylated GSTP1 promoters in Hep3B HCC cells, which fail to express GSTP1 mRNA or GSTP1 polypeptides, appears to be mediated by MBD2. Treatment of Hep3B cells with 5-azadeoxycytidine (5-aza-dC), a methyltransferase inhibitor, activated GSTP1 expression, whereas treatment with trichostatin A, a histone deacetylase inhibitor, had little effect. To more precisely assess the contribution of the pattern of GSTP1 CpG island methylation on GSTP1 mRNA expression, Hep3B cells were treated for 72 h with 5-aza-dC and then subjected to limiting dilution cloning. Bisulfite sequencing was used to map the methylation patterns of the GSTP1 promoter region in GSTP1-expressing and -non-expressing clones. In the clone that expressed GSTP1 mRNA determined by Northern blot analysis and quantitative reverse transcriptase (RT)-PCR, widespread demethylation of at least one GSTP1 allele was evident. Chromatin immunoprecipitation experiments revealed the presence of MBD2, but not Sp1, at the GSTP1 promoter in Hep3B cells. In contrast, Sp1 was detected at the GSTP1 promoter in a GSTP1-expressing Hep3B 5-aza-dC subclone. To test whether MBD2 might be responsible for the inhibition of GSTP1 transcription from hypermethylated GSTP1 promoters, siRNAs were used to reduce MBD2 polypeptide levels in Hep3B cells. SssI-catalyzed methylation of GSTP1 promoter sequences resulted in diminished luciferase reporter activity after transfection into Hep3B cells. However, when hypermethylated GSTP1 promoter sequences were transfected into Hep3B cells that had been treated with siRNA-targeting MBD2 mRNA, no repression of luciferase reporter expression was evident. These findings implicate MBD2 in the repression of GSTP1 expression associated with GSTP1 CpG island hypermethylation in HCC cells.
Similar articles
- Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ. Zhong S, et al. Clin Cancer Res. 2002 Apr;8(4):1087-92. Clin Cancer Res. 2002. PMID: 11948118 - GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.
Tchou JC, Lin X, Freije D, Isaacs WB, Brooks JD, Rashid A, De Marzo AM, Kanai Y, Hirohashi S, Nelson WG. Tchou JC, et al. Int J Oncol. 2000 Apr;16(4):663-76. doi: 10.3892/ijo.16.4.663. Int J Oncol. 2000. PMID: 10717233 - GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
Nakayama M, Gonzalgo ML, Yegnasubramanian S, Lin X, De Marzo AM, Nelson WG. Nakayama M, et al. J Cell Biochem. 2004 Feb 15;91(3):540-52. doi: 10.1002/jcb.10740. J Cell Biochem. 2004. PMID: 14755684 Review. - Clinical significance and association of GSTP1 hypermethylation with hepatocellular carcinoma: A meta-analysis.
Li Y, Cai Y, Chen H, Mao L. Li Y, et al. J Cancer Res Ther. 2018 Jun;14(Supplement):S486-S489. doi: 10.4103/0973-1482.181179. J Cancer Res Ther. 2018. PMID: 29970711 Review.
Cited by
- DNA methylation inhibitors: Retrospective and perspective view.
Uddin MG, Fandy TE. Uddin MG, et al. Adv Cancer Res. 2021;152:205-223. doi: 10.1016/bs.acr.2021.03.007. Epub 2021 May 4. Adv Cancer Res. 2021. PMID: 34353438 Free PMC article. - MBD2 Correlates with a Poor Prognosis and Tumor Progression in Renal Cell Carcinoma.
Li L, Li N, Liu N, Huo F, Zheng J. Li L, et al. Onco Targets Ther. 2020 Oct 7;13:10001-10012. doi: 10.2147/OTT.S256226. eCollection 2020. Onco Targets Ther. 2020. PMID: 33116585 Free PMC article. - DNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications.
Mahmood N, Rabbani SA. Mahmood N, et al. Front Oncol. 2019 Jun 11;9:489. doi: 10.3389/fonc.2019.00489. eCollection 2019. Front Oncol. 2019. PMID: 31245293 Free PMC article. Review. - Genistein and Trichostatin A Induction of Estrogen Receptor Alpha Gene Expression, Apoptosis and Cell Growth Inhibition in Hepatocellular Carcinoma HepG 2 Cells.
Sanaei M, Kavoosi F, Salehi H. Sanaei M, et al. Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3445-3450. doi: 10.22034/APJCP.2017.18.12.3445. Asian Pac J Cancer Prev. 2017. PMID: 29286617 Free PMC article. - Readers of DNA methylation, the MBD family as potential therapeutic targets.
Ginder GD, Williams DC Jr. Ginder GD, et al. Pharmacol Ther. 2018 Apr;184:98-111. doi: 10.1016/j.pharmthera.2017.11.002. Epub 2017 Nov 8. Pharmacol Ther. 2018. PMID: 29128342 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous